Speakers - ASCCP

Log In Create an Account

Save the Date!

2025 ASCCP

Scientific Meeting on Anogenital & HPV-Related Diseases

April 24-26, 2025

San Diego, CA
Meeting Overview

Program Overview

Speakers

Register to Attend

Exhibits / Sponsorships

Hotel Info

CME Info

Speakers
Prajakta Adsul, MD, PhD

is an Assistant Professor and a Member of the Cancer Control and Population Sciences Research Program, at the Comprehensive Cancer Center at University of New Mexico. She also serves as the Inaugural Director of the Center for Advancing Dissemination and Implementation Science. Dr. Adsul is a primary care physician by training and was a Cancer Prevention Fellow with the Implementation Science team at the National Cancer Institute. As an implementation scientist, she uses community-based participatory research approaches focused on health equity to test interventions and implementation strategies in pragmatic studies for cancer prevention and control.

is an Assistant Professor and a Member of the Cancer Control and Population Sciences Research Program, at the Comprehensive Cancer Center at University of New Mexico. She also serves as the Inaugural Director of the Center for Advancing Dissemination and Implementation Science. Dr. Adsul is a primary care physician by training and was a Cancer Prevention Fellow with the Implementation Science team at the National Cancer Institute. As an implementation scientist, she uses community-based participatory research approaches focused on health equity to test interventions and implementation strategies in pragmatic studies for cancer prevention and control.

Patty Cason, MS, FNP-BC

is a family nurse practitioner and educator with a specialty in sexual and reproductive health. She has practiced for 36 years in a wide variety of clinical settings. Patty developed the “PATH” framework for patient-centered reproductive counseling and she heads up the Sexual Agency Project. Patty is a senior author and editor of the recently published 21st edition of Contraceptive Technology. Her other publications include research and opinion pieces in peer reviewed journals, nationally utilized on-line learning courses, instructional videos, textbook chapters, clinical protocols, job aids and manuals on provision of sexual and reproductive health services and integration of sexual and reproductive health services into primary care settings.

is a family nurse practitioner and educator with a specialty in sexual and reproductive health. She has practiced for 36 years in a wide variety of clinical settings. Patty developed the “PATH” framework for patient-centered reproductive counseling and she heads up the Sexual Agency Project. Patty is a senior author and editor of the recently published 21st edition of Contraceptive Technology. Her other publications include research and opinion pieces in peer reviewed journals, nationally utilized on-line learning courses, instructional videos, textbook chapters, clinical protocols, job aids and manuals on provision of sexual and reproductive health services and integration of sexual and reproductive health services into primary care settings.

Christine Conageski, MD, MSc

is an Associate Professor in the Division of General Obstetrics and Gynecology at the University Colorado School of Medicine. She completed her medical school training at the University of Cincinnati and her Gynecology/Obstetrics residency at the University of Colorado. She also completed a Masters in Clinical Science through the Colorado Clinical and Translational Sciences Institute. Dr. Conageski is the Director of the University of Colorado Colposcopy Clinic. She practices general obstetrics and gynecology, and her clinical and research interests focus on HPV-associated diseases of the lower genital tract, screening disparities and infectious diseases of the lower genital tract. She has served as the course director for ASCCP Comprehensive Colposcopy course, as a member of the ASCCP Board of Directors, and is a member or chair of several ASCCP committees.

is an Associate Professor in the Division of General Obstetrics and Gynecology at the University Colorado School of Medicine. She completed her medical school training at the University of Cincinnati and her Gynecology/Obstetrics residency at the University of Colorado. She also completed a Masters in Clinical Science through the Colorado Clinical and Translational Sciences Institute. Dr. Conageski is the Director of the University of Colorado Colposcopy Clinic. She practices general obstetrics and gynecology, and her clinical and research interests focus on HPV-associated diseases of the lower genital tract, screening disparities and infectious diseases of the lower genital tract. She has served as the course director for ASCCP Comprehensive Colposcopy course, as a member of the ASCCP Board of Directors, and is a member or chair of several ASCCP committees.

Mark Einstein, MD, MS

is Professor and Chair of Obstetrics & Gynecology and Women’s Health at Montefiore Medical Center and the Chella and Moise Safra Endowed Chair of the Department at the Albert Einstein College of Medicine. He has served in numerous leadership roles for many national and international OB/GYN and cancer-focused groups including the World Health Organization, the US National Cancer Institute, ASCCP, the American Cancer Society, and the Society of Gynecologic Oncologists. He is a Past President of the ASCCP, the Society of Lower Genital Tract Diseases. He has led many domestic and international clinical and translational efforts identifying unique, potentially druggable, targets and biomarkers for clinical risk for screening and for malignant transformation. He has served in public policy roles in the US and globally as a leader in clinical guidelines development for various gynecologic diseases, including cervical cancer screening. He has also served in roles for the CDC and Departments of Health in guiding cancer prevention and control strategies, particularly in vulnerable and marginalized populations. He leads study sections for the National Cancer Institute and serves on study sections domestically and internationally and leads a number of domestic and internation trials in cancer prevention and treatment.

is Professor and Chair of Obstetrics & Gynecology and Women’s Health at Montefiore Medical Center and the Chella and Moise Safra Endowed Chair of the Department at the Albert Einstein College of Medicine. He has served in numerous leadership roles for many national and international OB/GYN and cancer-focused groups including the World Health Organization, the US National Cancer Institute, ASCCP, the American Cancer Society, and the Society of Gynecologic Oncologists. He is a Past President of the ASCCP, the Society of Lower Genital Tract Diseases. He has led many domestic and international clinical and translational efforts identifying unique, potentially druggable, targets and biomarkers for clinical risk for screening and for malignant transformation. He has served in public policy roles in the US and globally as a leader in clinical guidelines development for various gynecologic diseases, including cervical cancer screening. He has also served in roles for the CDC and Departments of Health in guiding cancer prevention and control strategies, particularly in vulnerable and marginalized populations. He leads study sections for the National Cancer Institute and serves on study sections domestically and internationally and leads a number of domestic and internation trials in cancer prevention and treatment.

Lisa Flowers, MD, MPH

is Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. Dr. Flowers joined the Emory faculty in 1999. She is active on many national and state committees aimed at improving the quality and delivery of care and service to patients with cervical and breast disease, including work with the American Society for Colposcopy and Cervical Pathology, American College of Obstetrics and Gynecology, and American Cancer Society. Dr. Flowers is a member of Alpha Omega Alpha Honor Society, the American College of Obstetricians and Gynecologists, International Anal Neoplasia Society and is a member and on the Board of Directors of American Society for Colposcopy and Cervical Pathology. She is also on the DHHS/CDC Breast and Cervical Cancer Early Detection and Control Advisory Committee. Dr. Lisa Flowers received her medical degree from Case Western Reserve University School of Medicine, in Cleveland, Ohio. She completed her residency in obstetrics and gynecology at Magee-Women’s Hospital of the University of Pittsburgh Medical Center in 1996. Dr. Flowers is board certified in obstetrics and gynecology. Dr. Flowers’ research interests include treatment for HPV-related disease, HPV and cervical cancer educational programs, and ovarian cancer surveillance for women with breast cancer susceptibility genes. She is currently the Emory Principal Investigator for several clinical trials entailing biomarker discovery, risk assessment and treatment for anal neoplasia. Dr. Flowers was ASCCP President 2022-2023.

is Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. Dr. Flowers joined the Emory faculty in 1999. She is active on many national and state committees aimed at improving the quality and delivery of care and service to patients with cervical and breast disease, including work with the American Society for Colposcopy and Cervical Pathology, American College of Obstetrics and Gynecology, and American Cancer Society. Dr. Flowers is a member of Alpha Omega Alpha Honor Society, the American College of Obstetricians and Gynecologists, International Anal Neoplasia Society and is a member and on the Board of Directors of American Society for Colposcopy and Cervical Pathology. She is also on the DHHS/CDC Breast and Cervical Cancer Early Detection and Control Advisory Committee. Dr. Lisa Flowers received her medical degree from Case Western Reserve University School of Medicine, in Cleveland, Ohio. She completed her residency in obstetrics and gynecology at Magee-Women’s Hospital of the University of Pittsburgh Medical Center in 1996. Dr. Flowers is board certified in obstetrics and gynecology. Dr. Flowers’ research interests include treatment for HPV-related disease, HPV and cervical cancer educational programs, and ovarian cancer surveillance for women with breast cancer susceptibility genes. She is currently the Emory Principal Investigator for several clinical trials entailing biomarker discovery, risk assessment and treatment for anal neoplasia. Dr. Flowers was ASCCP President 2022-2023.

Lisa Gabor, MD

Lisa Gabor, MD is an assistant professor in Gynecologic Oncology in the Department of Obstetrics, Gynecology, and Reproductive Health at Rutgers New Jersey Medical School. She received her Doctor of Medicine at Rutgers Robert Wood Johnson Medical School. Following residency in obstetrics and gynecology at New York Presbyterian - Columbia University Medical Center, she completed her fellowship in gynecologic oncology at Montefiore Medical Center/Albert Einstein College of Medicine. She is currently serving as the Junior Board Member on the ASCCP as well as the ASCCP delegate to the American Cancer Society HPV Roundtable.

Lisa Gabor, MD is an assistant professor in Gynecologic Oncology in the Department of Obstetrics, Gynecology, and Reproductive Health at Rutgers New Jersey Medical School. She received her Doctor of Medicine at Rutgers Robert Wood Johnson Medical School. Following residency in obstetrics and gynecology at New York Presbyterian - Columbia University Medical Center, she completed her fellowship in gynecologic oncology at Montefiore Medical Center/Albert Einstein College of Medicine. She is currently serving as the Junior Board Member on the ASCCP as well as the ASCCP delegate to the American Cancer Society HPV Roundtable.

Michael Gaisa, MD, PhD

is a professor of medicine at the Icahn School of Medicine at Mount Sinai in New York City. He directs the anal cancer prevention program for the Mount Sinai Health System.

is a professor of medicine at the Icahn School of Medicine at Mount Sinai in New York City. He directs the anal cancer prevention program for the Mount Sinai Health System.

Francisco A. R. Garcia, MD, MPH

is the Chief of Staff to President Suresh Garimella of the University of Arizona. He is currently the ASCCP President and an active member of the Executive Committee.

is the Chief of Staff to President Suresh Garimella of the University of Arizona. He is currently the ASCCP President and an active member of the Executive Committee.

Katherine Hall, PhD

is an associate professor at the University of Mississippi Medical Center School of Nursing, earning her PhD in Nursing in 2019. As an early-stage investigator, her research has focused on the vast social, structural, and biological factors that influence women’s health, exploring both single and multi-faceted determinants of health for people in Mississippi and surrounding regions. In 2021, Dr. Hall began her work within the STRIDES study, focusing on the critical follow-up discrepancies among people receiving cervical care within Mississippi’s public health system. Her efforts have centered on identifying patients lacking follow-up diagnostic or management interventions, encouraging their return, and investigating the social and structural barriers that impede access to care. Her leadership extends to partnerships with UMMC and the Mississippi State Department of Health to establish sustainable solutions to improve women’s healthcare throughout our state.

is an associate professor at the University of Mississippi Medical Center School of Nursing, earning her PhD in Nursing in 2019. As an early-stage investigator, her research has focused on the vast social, structural, and biological factors that influence women’s health, exploring both single and multi-faceted determinants of health for people in Mississippi and surrounding regions. In 2021, Dr. Hall began her work within the STRIDES study, focusing on the critical follow-up discrepancies among people receiving cervical care within Mississippi’s public health system. Her efforts have centered on identifying patients lacking follow-up diagnostic or management interventions, encouraging their return, and investigating the social and structural barriers that impede access to care. Her leadership extends to partnerships with UMMC and the Mississippi State Department of Health to establish sustainable solutions to improve women’s healthcare throughout our state.

Warner K. Huh, MD, MSHA

is Chair of the Department of Obstetrics and Gynecology and holds the Charles E. Flowers, Jr. Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB). He is also Professor in the Department of Surgery and Professor in the Department of Epidemiology in the UAB School of Public Health.

is Chair of the Department of Obstetrics and Gynecology and holds the Charles E. Flowers, Jr. Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB). He is also Professor in the Department of Surgery and Professor in the Department of Epidemiology in the UAB School of Public Health.

Michelle J. Khan, MD, MPH

is a practicing obstetrician-gynecologist who has been working in the field of HPV cancer prevention for the past 22 years. She is fellowship trained in Reproductive Infectious Diseases. She is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at Stanford University School of Medicine. Dr. Khan directs the PEACH Program (Prevention and Education of Anogenital Cancers and HPV-associated diseases) and serves as Co-Director of the DEI Committee. She is active in the ASCCP and currently serves as President-Elect.

is a practicing obstetrician-gynecologist who has been working in the field of HPV cancer prevention for the past 22 years. She is fellowship trained in Reproductive Infectious Diseases. She is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at Stanford University School of Medicine. Dr. Khan directs the PEACH Program (Prevention and Education of Anogenital Cancers and HPV-associated diseases) and serves as Co-Director of the DEI Committee. She is active in the ASCCP and currently serves as President-Elect.

Lindsay Kuroki, MD, MSCI

is an Associate Professor in the Department of ObGyn at Washington University School of Medicine (WUSM) in St. Louis and serves as the Associate Division Director of Gynecologic Oncology. Her research is focused on identifying and testing strategies that achieve health equity and reduce gynecologic cancer disparities by addressing unmet social needs. She has published over 50 peer-reviewed articles and transitioned her KL2 career development award into further funding from the NIH, AAOGF, P20 Collaborative Cancer Disparities Research Program at WUSM, and the Implementation Science Center for Cancer Control.

is an Associate Professor in the Department of ObGyn at Washington University School of Medicine (WUSM) in St. Louis and serves as the Associate Division Director of Gynecologic Oncology. Her research is focused on identifying and testing strategies that achieve health equity and reduce gynecologic cancer disparities by addressing unmet social needs. She has published over 50 peer-reviewed articles and transitioned her KL2 career development award into further funding from the NIH, AAOGF, P20 Collaborative Cancer Disparities Research Program at WUSM, and the Implementation Science Center for Cancer Control.

Yuxin Liu, MD

is a Professor of Pathology in the Division of Gynecologic Pathology, Icahn School of Medicine at Mount Sinai, New York City. She has a strong academic interest in the field of HPV-associated anal cancer and cervical cancer.

is a Professor of Pathology in the Division of Gynecologic Pathology, Icahn School of Medicine at Mount Sinai, New York City. She has a strong academic interest in the field of HPV-associated anal cancer and cervical cancer.

L. Stewart Massad, MD

is a Professor in the Division of Gynecologic Oncology at Washington University in St. Louis. He has been presenting at ASCCP scientific meetings since 1992 and was co-author of ASCCP guidelines 2001-2012. He was a member of the Enduring Guidelines leadership until 2024.

is a Professor in the Division of Gynecologic Oncology at Washington University in St. Louis. He has been presenting at ASCCP scientific meetings since 1992 and was co-author of ASCCP guidelines 2001-2012. He was a member of the Enduring Guidelines leadership until 2024.

E.J. Mayeaux, Jr., MD

is Medical Director of Ambulatory Quality Management, and Family Medicine Associate Program Director for Lexington Medical Center, Lexington SC, and Professor Emeritus of Family Medicine at LSUHSC in Shreveport, Louisiana, USA. He is board certified in Family Medicine and Preventive Medicine–Clinical Informatics. Dr. Mayeaux has been an active member of the American Society for Colposcopy and Cervical Pathology (ASCCP) and the International Federation for Colposcopy and Pathology of the Cervix (IFCPC) since 1996. He is currently on the executive board of IFCPC and was ASCCP President in 2014. He serves on a number of committees. He was the lead editor of Modern Colposcopy, 3rd edition, the flagship publication on colposcopy from the ASCCP. He regularly lectures all over the world on a variety of women's health, skin diseases, leadership, and primary care topics. Dr. Mayeaux’s clinical expertise includes women’s health topics such as cervical disease, HPV disease, HPV vaccination, skin diseases and patient literacy as it relates to clinical medicine. He also speaks regularly on leadership topics, population health, disparities in healthcare, skin diseases, skin surgery, medical burnout, joy in medicine, and other topics. He has dedicated the greatest part of his professional life to the study and practice of women's health.

is Medical Director of Ambulatory Quality Management, and Family Medicine Associate Program Director for Lexington Medical Center, Lexington SC, and Professor Emeritus of Family Medicine at LSUHSC in Shreveport, Louisiana, USA. He is board certified in Family Medicine and Preventive Medicine–Clinical Informatics. Dr. Mayeaux has been an active member of the American Society for Colposcopy and Cervical Pathology (ASCCP) and the International Federation for Colposcopy and Pathology of the Cervix (IFCPC) since 1996. He is currently on the executive board of IFCPC and was ASCCP President in 2014. He serves on a number of committees. He was the lead editor of Modern Colposcopy, 3rd edition, the flagship publication on colposcopy from the ASCCP. He regularly lectures all over the world on a variety of women's health, skin diseases, leadership, and primary care topics. Dr. Mayeaux’s clinical expertise includes women’s health topics such as cervical disease, HPV disease, HPV vaccination, skin diseases and patient literacy as it relates to clinical medicine. He also speaks regularly on leadership topics, population health, disparities in healthcare, skin diseases, skin surgery, medical burnout, joy in medicine, and other topics. He has dedicated the greatest part of his professional life to the study and practice of women's health.

Jane R. Montealegre, PhD, MPH

is an Associate Professor at The University of Texas MD Anderson Cancer Center. She is a Behavioral Epidemiologist and Implementation Scientist with research expertise in the design, implementation, and evaluation of community- and health system-based interventions to address cancer health disparities. Her research focuses on the prevention and early detection of cervical and other human papillomavirus (HPV)-associated cancers in underserved and minoritized populations. A significant part of Dr. Montealegre’s research is around the implementation of self-collection for primary HPV testing to improve access to and utilization of cervical cancer screening in underserved populations.

is an Associate Professor at The University of Texas MD Anderson Cancer Center. She is a Behavioral Epidemiologist and Implementation Scientist with research expertise in the design, implementation, and evaluation of community- and health system-based interventions to address cancer health disparities. Her research focuses on the prevention and early detection of cervical and other human papillomavirus (HPV)-associated cancers in underserved and minoritized populations. A significant part of Dr. Montealegre’s research is around the implementation of self-collection for primary HPV testing to improve access to and utilization of cervical cancer screening in underserved populations.

Akiva P. Novetsky, MD, MS

is an Associate Professor in the Department of Obstetrics and Gynecology at Westchester Medical Center/New York Medical College. He also serves as the Associate Chair of the Department of Obstetrics and Gynecology for Quality and Safety. Dr. Novetsky obtained his bachelor’s degree in biology from Yeshiva University and a medical degree from Albert Einstein College of Medicine. He is board certified in obstetrics and gynecology with subspecialty certification in gynecologic oncology. Dr. Novetsky is an active member of the American Society for Colposcopy and Cervical Pathology (ASCCP) and serves as a Member-at-Large on the ASCCP Board of Directors. He was the Chair of the 2020, 2021 and 2022 Annual Scientific Meetings. Additionally, he has served as Past Chair of the ASCCP Assessment Committee and continues to serve as a member of the Education and Finance Committees. He is an Associate Editor for the Journal of Lower Genital Tract Disease and serves as a reviewer for multiple other journals. Dr. Novetsky served on the working groups that developed the Colposcopy Standards Guidelines, published in 2017 and on the working group and Steering Committee for the development of the 2019 Management Guidelines. He also serves as a Co-Chair of one of the working groups in the American Cancer Society Initiative to transition to primary HPV screening. Dr. Novetsky’s clinical expertise includes women’s cancers including: cervical, uterine, ovarian, vulvar and vaginal cancers as well as the pre-malignant conditions associated with these diseases.

is an Associate Professor in the Department of Obstetrics and Gynecology at Westchester Medical Center/New York Medical College. He also serves as the Associate Chair of the Department of Obstetrics and Gynecology for Quality and Safety. Dr. Novetsky obtained his bachelor’s degree in biology from Yeshiva University and a medical degree from Albert Einstein College of Medicine. He is board certified in obstetrics and gynecology with subspecialty certification in gynecologic oncology. Dr. Novetsky is an active member of the American Society for Colposcopy and Cervical Pathology (ASCCP) and serves as a Member-at-Large on the ASCCP Board of Directors. He was the Chair of the 2020, 2021 and 2022 Annual Scientific Meetings. Additionally, he has served as Past Chair of the ASCCP Assessment Committee and continues to serve as a member of the Education and Finance Committees. He is an Associate Editor for the Journal of Lower Genital Tract Disease and serves as a reviewer for multiple other journals. Dr. Novetsky served on the working groups that developed the Colposcopy Standards Guidelines, published in 2017 and on the working group and Steering Committee for the development of the 2019 Management Guidelines. He also serves as a Co-Chair of one of the working groups in the American Cancer Society Initiative to transition to primary HPV screening. Dr. Novetsky’s clinical expertise includes women’s cancers including: cervical, uterine, ovarian, vulvar and vaginal cancers as well as the pre-malignant conditions associated with these diseases.

Joel Palefsky, MD, CM, FRCP(C)

is the Professor of Medicine and Infectious Diseases at the University of California San Francisco. He is the founder/director of the world's first clinic devoted to prevention of anal cancer, the UCSF Anal Neoplasia Clinic Research and Education Center. He is the vice-chair of the National Cancer Institute (NCI)-supported AIDS Malignancy Consortium. He is the chair of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study.. He is founder and past president of the International Anal Neoplasia Society and past president of the International Papillomavirus Society (IPVS). He is founder and director of IPVS Society International HPV Awareness campaign.

is the Professor of Medicine and Infectious Diseases at the University of California San Francisco. He is the founder/director of the world's first clinic devoted to prevention of anal cancer, the UCSF Anal Neoplasia Clinic Research and Education Center. He is the vice-chair of the National Cancer Institute (NCI)-supported AIDS Malignancy Consortium. He is the chair of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study.. He is founder and past president of the International Anal Neoplasia Society and past president of the International Papillomavirus Society (IPVS). He is founder and director of IPVS Society International HPV Awareness campaign.

Carolann Risley, PhD, WHNP-C

is an Associate Professor at the University of Mississippi Medical Center (UMMC) School of Nursing. She holds secondary appointments in the School of Medicine Department of Cell and Molecular Biology and the Cancer Center and Research Institute. In 1992, she earned a master's degree at the University of Pennsylvania and became certified as a women's health nurse practitioner. In 2019, she earned a Ph.D. at the UMMC School of Graduate Studies and went on to complete a postdoctoral fellowship in the National Cancer Institute's Clinical Genetics Branch. Currently, at the UMMC, she is a Mississippi Center for Clinical and Translational Research Scholar and is the PI of the STRIDES study, (Studying Risk to Improve DisparitiES in cervical cancer in Mississippi), a study co-led by investigators at the UMMC, the Mississippi Department of Health, and the National Cancer Institute. Additionally, she is leading efforts with the Centers for Disease Control and Prevention and the MITRE corporation to develop a clinical decision support tool for cervical cancer screening and management in the electronic medical record.

is an Associate Professor at the University of Mississippi Medical Center (UMMC) School of Nursing. She holds secondary appointments in the School of Medicine Department of Cell and Molecular Biology and the Cancer Center and Research Institute. In 1992, she earned a master's degree at the University of Pennsylvania and became certified as a women's health nurse practitioner. In 2019, she earned a Ph.D. at the UMMC School of Graduate Studies and went on to complete a postdoctoral fellowship in the National Cancer Institute's Clinical Genetics Branch. Currently, at the UMMC, she is a Mississippi Center for Clinical and Translational Research Scholar and is the PI of the STRIDES study, (Studying Risk to Improve DisparitiES in cervical cancer in Mississippi), a study co-led by investigators at the UMMC, the Mississippi Department of Health, and the National Cancer Institute. Additionally, she is leading efforts with the Centers for Disease Control and Prevention and the MITRE corporation to develop a clinical decision support tool for cervical cancer screening and management in the electronic medical record.

Peter F. Schnatz, DO

is a Professor at Drexel University and the Medical Director of the FaithCare PA Health Center. He is a Past President of the Menopause Society and the Philadelphia ObGyn Society and a current board member of the ASCCP, the International Menopause Society, the Advancing Health After Hysterectomy Foundation, and FaithCare.

is a Professor at Drexel University and the Medical Director of the FaithCare PA Health Center. He is a Past President of the Menopause Society and the Philadelphia ObGyn Society and a current board member of the ASCCP, the International Menopause Society, the Advancing Health After Hysterectomy Foundation, and FaithCare.

Sangini S. Sheth, MD, MPH

is associate professor and interim director for the division of Gynecologic Specialties, Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine. She is the inaugural Vice Chair for Diversity, Equity, and Inclusion in the department. Dr. Sheth's clinical and public health backgrounds have guided her research interests in optimizing reproductive healthcare among marginalized groups. Sangini is an NIH and CDC-funded investigator. Her current work focuses on applying implementation science to cervical cancer prevention across the care continuum locally and globally, with projects in New Haven, Mexico, and Nepal.

is associate professor and interim director for the division of Gynecologic Specialties, Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine. She is the inaugural Vice Chair for Diversity, Equity, and Inclusion in the department. Dr. Sheth's clinical and public health backgrounds have guided her research interests in optimizing reproductive healthcare among marginalized groups. Sangini is an NIH and CDC-funded investigator. Her current work focuses on applying implementation science to cervical cancer prevention across the care continuum locally and globally, with projects in New Haven, Mexico, and Nepal.

Elizabeth Stier, MD

is a professor in Gynecology at Boston University Chobanian and Avedisian School of Medicine. With expertise in the diagnosis and management of HPV associated diseases, Beth Stier is working towards cervical, anal, and vulva cancer prevention for all people regardless of gender. Dr. Stier was the chair of the HPV Working Group of the AIDS Malignancy Consortium and a member of the CDC-sponsored HPV disease committee, Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents.

is a professor in Gynecology at Boston University Chobanian and Avedisian School of Medicine. With expertise in the diagnosis and management of HPV associated diseases, Beth Stier is working towards cervical, anal, and vulva cancer prevention for all people regardless of gender. Dr. Stier was the chair of the HPV Working Group of the AIDS Malignancy Consortium and a member of the CDC-sponsored HPV disease committee, Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents.

Susan Vadaparampil, PhD, MPH

is Senior Member and Professor in the Department of Health Outcomes and Behavior at Moffitt Cancer Center. Her research focuses on breast and cervical cancer prevention/early detection. Dr. Vadaparampil is Co-Program Director of Moffitt’s NCI funded T32 Behavioral Oncology and Career Development program. In 2019, Dr. Vadaparampil was appointed as Moffitt’s inaugural Associate Center Director for Community Outreach, Engagement & Equity. She has been recognized for her outstanding scientific contributions through her appointments from 2020-2024 to the National Cancer Advisory Board and as Co-Chair of the ACS National Roundtable on Cervical Cancer in 2023.

is Senior Member and Professor in the Department of Health Outcomes and Behavior at Moffitt Cancer Center. Her research focuses on breast and cervical cancer prevention/early detection. Dr. Vadaparampil is Co-Program Director of Moffitt’s NCI funded T32 Behavioral Oncology and Career Development program. In 2019, Dr. Vadaparampil was appointed as Moffitt’s inaugural Associate Center Director for Community Outreach, Engagement & Equity. She has been recognized for her outstanding scientific contributions through her appointments from 2020-2024 to the National Cancer Advisory Board and as Co-Chair of the ACS National Roundtable on Cervical Cancer in 2023.

Nicolas Wentzensen, MD, PhD, MS

is Head of the Clinical Epidemiology Unit and Deputy Director of the Clinical Genetics Branch in the Division of Cancer Epidemiology and Genetics at the NCI. He is a Medical Doctor with a PhD in Applied Tumour Biology, and a Masters degree in Epidemiology. He has held numerous leadership and participant roles in committees and organizations relevant to cervical cancer, including the IARC Handbook on cervical cancer screening (Co-lead), previous iterations of ACS screening guidelines (WG lead), the US Colposcopy Standards (Co-lead), the US Consensus Management Guidelines (Steering Committee, WG lead), and the US Enduring Guidelines effort (Co-lead).

is Head of the Clinical Epidemiology Unit and Deputy Director of the Clinical Genetics Branch in the Division of Cancer Epidemiology and Genetics at the NCI. He is a Medical Doctor with a PhD in Applied Tumour Biology, and a Masters degree in Epidemiology. He has held numerous leadership and participant roles in committees and organizations relevant to cervical cancer, including the IARC Handbook on cervical cancer screening (Co-lead), previous iterations of ACS screening guidelines (WG lead), the US Colposcopy Standards (Co-lead), the US Consensus Management Guidelines (Steering Committee, WG lead), and the US Enduring Guidelines effort (Co-lead).

Privacy Policy:

By using this site, you agree to the Privacy Policy and acknowledge the use of cookies to store information, which may be essential to making our site work properly or enhancing user experience.